首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   5308篇
  免费   365篇
  国内免费   30篇
耳鼻咽喉   50篇
儿科学   192篇
妇产科学   159篇
基础医学   666篇
口腔科学   86篇
临床医学   361篇
内科学   1137篇
皮肤病学   111篇
神经病学   441篇
特种医学   180篇
外科学   1117篇
综合类   53篇
一般理论   2篇
预防医学   430篇
眼科学   132篇
药学   293篇
  1篇
中国医学   30篇
肿瘤学   262篇
  2023年   40篇
  2022年   50篇
  2021年   149篇
  2020年   84篇
  2019年   135篇
  2018年   148篇
  2017年   121篇
  2016年   128篇
  2015年   120篇
  2014年   151篇
  2013年   198篇
  2012年   266篇
  2011年   311篇
  2010年   216篇
  2009年   186篇
  2008年   244篇
  2007年   299篇
  2006年   238篇
  2005年   246篇
  2004年   199篇
  2003年   220篇
  2002年   198篇
  2001年   164篇
  2000年   207篇
  1999年   155篇
  1998年   81篇
  1997年   66篇
  1996年   46篇
  1995年   50篇
  1994年   46篇
  1993年   28篇
  1992年   94篇
  1991年   85篇
  1990年   76篇
  1989年   72篇
  1988年   51篇
  1987年   56篇
  1986年   45篇
  1985年   47篇
  1984年   38篇
  1983年   29篇
  1982年   26篇
  1981年   23篇
  1980年   25篇
  1979年   18篇
  1975年   16篇
  1974年   15篇
  1973年   31篇
  1972年   21篇
  1971年   19篇
排序方式: 共有5703条查询结果,搜索用时 15 毫秒
101.
BACKGROUND: Heparin resistance is an important clinical problem traditionally treated with additional heparin or fresh frozen plasma. We undertook a randomized clinical trial to determine if treatment with antithrombin (AT) concentrate is effective for treating this condition. METHODS: Patients requiring cardiopulmonary bypass who were considered to be heparin resistant (activated clotting time < 480 seconds after > 450 IU/kg heparin) were randomized to receive either 1000 U AT or additional heparin. RESULTS: AT concentrate was effective in 42 of 44 patients (96%) for immediately obtaining a therapeutic activated clotting time. This compared favorably to 28 of 41 patients (68%) treated with additional heparin (p = 0.001). All patients who failed heparin therapy were successfully treated with AT. The patients receiving AT required less time to obtain an adequate ACT but there was no difference in clinical outcomes among the groups. Study patients had deficient AT activity at baseline (56%+/-25%), which improved in those given AT concentrate (75%+/-31% versus 50%+/-23%, p < 0.0005). CONCLUSIONS: Heparin resistance is frequently associated with AT deficiency. Treating this deficiency with AT concentrate is more effective and faster for obtaining adequate anticoagulation than using additional heparin.  相似文献   
102.
IntroductionAlthough several tools have been developed to assess general HRQoL in children, parental reports are required to supplement this information, especially in very young children. The parents version of the Kiddy-KINDL-R was developed to assess HRQoL in children aged 3 to 7 years through the reports of their parents or legal guardians.ObjectiveThe aim of this study was to validate the parents version of the Kiddy-KINDL-R questionnaire and assess its psychometric properties in a sample of Spanish preschool-aged children.MethodCross-sectional study in 283 parents or legal guardians of children aged 3 to 6 years that completed the Kiddy-KINDL-R questionnaire and an additional scale to assess anxiety problems. We performed confirmatory factor analysis to assess whether the original Kiddy-KINDL-R version fit the Spanish data; we assessed internal consistency by means of the ordinal alpha and the discriminant validity by means of the Preschool Anxiety Scale.ResultsAlthough the original six-factor model showed a good fit, we propose a model consisting of 22 items and the same 6 factors for the Spanish version. The reliability was excellent, and the internal consistency values were adequate. Our results showed significant negative correlations between the Kiddy-KINDL-R and the external anxiety measure, which was evidence of discriminant validity.ConclusionWe demonstrated that the Spanish version of the Kiddy-KINDL-R had good psychometric properties and that this questionnaire is an adequate assessment tool that could be useful in clinical practice.  相似文献   
103.
104.
105.
106.
107.
108.
109.
110.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号